Received Oct 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4SB5S | — |
improper preparation of vaccine; Inappropriate preparation of medication; Accidental exposure to product; This non-serious case was reported by a other health professional via call center representative and described the occurrence of exposure via skin contact in a 35-year-old female patient who received MMR (Priorix) (batch number 4SB5S) for prophylaxis. On 30-SEP-2025, the patient received Priorix. On 30-SEP-2025, an unknown time after receiving Priorix, the patient experienced exposure via skin contact (Verbatim: improper preparation of vaccine), inappropriate preparation of medication (Verbatim: Inappropriate preparation of medication ) and accidental exposure to product (Verbatim: Accidental exposure to product). The outcome of the exposure via skin contact, inappropriate preparation of medication and accidental exposure to product were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 30-SEP-2025 Reporter stated about a leaky Priorix syringe after reconstitution. She did not used a Luer-Lok need to mix the medication. PQC ruled out. Reporter stated that the Medication leaked on her hand.